Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Sigma A6730 | 3.0 | uM | 3 | MIP-1B | 61.5 | 70 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | MIP-1B | 64.0 | 67 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1B | 60.0 | 69 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1B | 57.0 | 79 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1B | 66.0 | 75 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1B | 57.5 | 66 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | MIP-1B | 62.5 | 68 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | MIP-1B | 63.0 | 85 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 134.0 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 79.5 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 63.5 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 160.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 117.5 | 74 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 64.0 | 67 | |
RA2159 | PI103 | 0.1 | uM | 3 | MIP-1B | 59.0 | 64 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 158.0 | 83 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 134.0 | 65 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 214.0 | 74 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 466.5 | 78 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 60.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1B | 76.0 | 73 | |
N2586 | PI103 | 0.1 | uM | 3 | MIP-1B | 61.0 | 73 | ||||
0 | MIP-1B | 64.0 | 69 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | MIP-1B | 77.0 | 47 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1B | 86.0 | 45 |